UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported):

December 12, 2013

MEDPRO SAFETY PRODUCTS, INC.

(Exact Name of Registrant as Specified in its Charter)

145 Rose Street

Lexington, KY 40507

(Address of Principal Executive Offices) (Zip Code)

(859) 225-5375

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

On December 24, 2013, MedPro Safety Products, Inc. (“MedPro” or the “Company”) and its principal shareholder Vision Opportunity Master Fund, Ltd. (“VOMF”) entered into an amendment to MedPro’s Series D Senior Secured Promissory Note (the “Series D Note”). The amendment extends the maturity date of the Series D Note from December 31, 2013 to March 31, 2014 and increases the interest rate on the outstanding principal balance of the Series D Note from 10% to 15% during the extension period. All other terms and conditions of the Series D Note remain unmodified and in full force and effect. In addition, MedPro granted VOMF the right to appoint one member to MedPro’s board of directors any time there remains outstanding principal on the Series D Note.

The outstanding principal balance of the Series D Note is currently $4,310,000. The terms and conditions of the Series D Note are described in MedPro’s Current Report on Form 8-K filed September 18, 2012.

On December 23, 2013, Marc T. Ray resigned from his position as MedPro’s Chief Financial Officer and Vice President of Finance, effective immediately.  The Company has not designated a successor at this time.

On December 12, 2013, Andrew P. Merkatz resigned as a director of the Company. Mr Merkatz had served as the designated representative of VOMF on MedPro’s board of directors since March 18, 2013.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

Exhibit 10.1

December 24, 2013

MedPro Safety Products, Inc.

817 Winchester Road, Suite 200

Lexington, KY 40505

Attn: Craig Turner

Dear Craig:

Reference is made to that certain Series D Senior Secured Promissory Note dated September 12, 2012 (the "Series D Note"), made by MedPro Safety Products, Inc. ("MedPro") to Vision Opportunity Master Fund, Ltd. ("Vision") and to that certain Secured Promissory Note dated December 12, 2013, made by MedPro to Vision (the "Promissory Note" and together with the Series D Note collectively referred to as the "Notes"). Capitalized terms used herein but not defined shall have the definitions set forth in the Notes.

WHEREAS, the parties acknowledge that the aggregate outstanding principal on the Notes totals $4,310,000 (the "Outstanding Principal");

WHEREAS, the parties acknowledge that the Notes are set to mature on December 31, 2013 (the "Maturity Date");

WHEREAS, MedPro wishes for vision to extend the Maturity Date of the Notes for a period of three (3) months (the "Extension Period") such that the new maturity date shall be March 31, 2014 (the "New Maturity Date") and Vision has, therefore, requested as consideration for this extension, that during the Extension Period the Notes shall carry an increased interest rate of 15% per annum and that Vision receives the right to appoint one (1) member to the MedPro board of directors (the "Board"), which right may be exercised anytime while there remains any Outstanding Principal.

For good and valuable consideration, the sufficiency and receipt of which is hereby acknowledged, Vision hereby agrees to extend the Notes to the New Maturity Date and MedPro agrees to pay an increased interest rate of 15% per annum on the Outstanding Principal during the Extension Period and afford Vision the right to appoint one (1) member to the Board which right may be exercised anytime while there remains any Outstanding Principal.

Except as provided herein, all other terms and provisions of the Notes shall remain unmodified and in full force and effect.

[Signatures are on the following page]

Read, consented and agreed to:

MEDPRO SAFETY PRODUCTS, INC.